Related references
Note: Only part of the references are listed.Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
Ting-ting Wang et al.
GUT (2017)
Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human
Lisa Andzinski et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Survival of residual neutrophils and accelerated myelopoiesis limit the efficacy of antibody-mediated depletion of Ly-6G+ cells in tumor-bearing mice
Katrin Moses et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy
Serena Zilio et al.
VACCINES (2016)
Neutrophils in cancer: neutral no more
Seth B. Coffelt et al.
NATURE REVIEWS CANCER (2016)
Distinct Functions of Neutrophil in Cancer and Its Regulation
Zvi Granot et al.
MEDIATORS OF INFLAMMATION (2015)
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Seth B. Coffelt et al.
NATURE (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment
Ronit Vogt Sionov et al.
CANCER MICROENVIRONMENT (2015)
Tumor-induced perturbations of cytokines and immune cell networks
Brett Burkholder et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17-A new mechanism of impaired antitumor immunity
Inbal Mishalian et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Evgeniy B. Eruslanov et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
Meixiao Shen et al.
PLOS ONE (2014)
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Inbal Mishalian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Modulation of CD8+ T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells
Elio Schouppe et al.
IMMUNOBIOLOGY (2013)
Neutrophils Confer T Cell Resistance to Myeloid-Derived Suppressor Cell-Mediated Suppression To Promote Chronic Inflammation
Sean O. Ryan et al.
JOURNAL OF IMMUNOLOGY (2013)
Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
Jinpu Yu et al.
JOURNAL OF IMMUNOLOGY (2013)
Reciprocal Relationship between Myeloid-Derived Suppressor Cells and T Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2013)
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
Claudia A. Dumitru et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives
Patrick Raber et al.
IMMUNOLOGICAL INVESTIGATIONS (2012)
Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
Minu K. Srivastava et al.
PLOS ONE (2012)
Rat mesenchymal stromal cells inhibitT cell proliferation but not cytokine production tnrough inducible nitric oxide synthase
Severin Zinocker et al.
FRONTIERS IN IMMUNOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Barbara Molon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
Suzanne Ostrand-Rosenberg
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Minu K. Srivastava et al.
CANCER RESEARCH (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Modulation of human neutrophil survival and antigen expression by activated CD4+ and CD8+ T cells
Martin Pelletier et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases
Steven C. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer
Rita Rotondo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?
Ingrid Mueller et al.
TRENDS IN IMMUNOLOGY (2009)
Transforming growth factor β subverts the immune system into directly promoting tumor growth through interleukin-17
Jeong-Seok Nam et al.
CANCER RESEARCH (2008)
A novel small-molecule inhibitor of transforming growth factor β type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection
Eiji Suzuki et al.
CANCER RESEARCH (2007)
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion
AH Zea et al.
CANCER RESEARCH (2005)
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease
P Sinha et al.
JOURNAL OF IMMUNOLOGY (2005)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species
S Kusmartsev et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells
ACP Diederichsen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
L-arginine metabolism in myeloid cells controls T-lymphocyte functions
V Bronte et al.
TRENDS IN IMMUNOLOGY (2003)
Nitric oxide-independent CTL suppression during tumor progression: Association with arginase-producing (M2) myeloid cells
YQ Liu et al.
JOURNAL OF IMMUNOLOGY (2003)
Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection
M Friberg et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism
A Mazzoni et al.
JOURNAL OF IMMUNOLOGY (2002)
Tumor-infiltrating macrophages induce apoptosis in activated CD8+ T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide
M Saio et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
